Inscripta: MAD7 CRISPR enzyme widely adopted in first year of availability

Inscripta: MAD7 CRISPR enzyme widely adopted in first year of availability

BOULDER -- Inscripta , a gene-editing technology company, today announced MAD7, its proprietary CRISPR enzyme, has achieved wide adoption by academic, commercial, and government researchers in... Read More

Thursday December 20, 2018 Tags: Boulder, Inscripta, MAD7, Kevin Ness

Inscripta announces two major milestones

Inscripta announces two major milestones

BOULDER -- Inscripta , a gene-editing technology company, announced two significant milestones. First, the USPTO granted Inscripta its first patent covering systems using MAD7, the... Read More

Friday July 13, 2018 Tags: Boulder, Inscripta, Dr. Kevin Ness, Jon Moore, MAD7, MAD2

IN Sponsors

Content Garden ad

Browse

InnovatioNews ends 9-year run covering Colorado innovation
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
A New Sunrise. Stakeholders all await, shapes a path to success too few even see. How often you get & answer questions is one indicator of your readiness
InnovatioNews on Spring hiatus until May 13
InnovatioNews on Spring hiatus until May 13
The Coming Drone Delivery Revolution – What Comes Next?
The Coming Drone Delivery Revolution – What Comes Next?
Primavera Essentials introduces Neuro-Eze
Primavera Essentials introduces Neuro-Eze

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.